COVID-19

Consensus statement of the International League against epilepsy and the International Federation of Clinical Neurophysiology

In this article the authors reviewed the scientific literature on movement disorders associated with Covid-19 published in English, spanning from the initial descriptions of COVID-19.

The objective of this multicentre retrospective cohort study was to develop and validate models that predict mortality of patients diagnosed with COVID-19 admitted to the hospital.

The objective of this study was to estimate the frequency of headache in patients with confirmed COVID-19 and characterize the phenotype of headache attributed to COVID-19, comparing patients depending on sex and the need for hospitalisation.

The aim of this study was to report orbital and visual pathways MRI findings in a nationwide multicenter cohort of patients with severe COVID-19.

COVID-19 has been associated with various neurological and atypical HEENT (head/eyes/eyes/nose/throat) manifestations. In this systematic review and meta-analysis the authors sought to review the evidence for these manifestations.

For August 2021, we have selected two COVID-19 papers of the month, investigating the effectiveness of the Covid-19 vaccines in England and Israel, respectively.

In this article the authors describe the case of a COVID-19 patient who developed bilateral occipital lobe haemorrhages suggestive of haemorrhagic PRES.

In this article the authors aimed to investigate the consequences of the first COVID-19 lockdown (mid-March - mid-April 2020) on motor and non-motor symptoms (NMS) in a cohort of French people with Parkinson's disease (PwP).

In this article the authors aimed to evaluate the effects of the COVID-19 pandemic on the quality of life (QoL) and perceived disease burden of this group of patients.

In this article the authors aimed to describe the neuropathological findings in SARS-CoV-2 infected patients who died during the COVID-19 pandemic, and define and quantify the presence of virus in selected areas showing pathological signs.

In this study, the authors analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19.

In this article the authors report two male patients, aged 45 and 67, who developed a classical form of PD approximately three months after a moderate COVID-19 infection with dyspnea, fever, anosmia and ageusia.

In this review, the authors summarize the current knowledge on epidemiology, clinical manifestation, and pathophysiology of ischemic stroke in patients with COVID-19 to bridge the gap from bench to bedside and clinical practice during the most challenging global health crisis of the last decades.

The purpose of this study was to report real-life safety data of the BNT162b2 COVID-19 vaccine in a cohort of MS patients.